Definitive Contract HDTRA121C0005
Award Date
10/5/20
Potential Completion Date
12/4/24
Potential Value
$26M
Federal Agency
Defense Threat Reduction Agency
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AC33 - National Defense R&D Services; Defense-Related Activities; Experimental Development
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
BOWLING GREEN, NY 10004, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This definitive, firm fixed price contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the International AIDS Vaccine Initiative (IAVI) to advance the development of monovalent vaccines for prevention of Marburg virus (MARV) and Sudan ebolavirus (SUDV) disease. The contract has a ceiling value of $166,898,763.00 and a completion date of September 29, 2027. It does not have a set-aside designation. IAVI is partnering with several subcontractors,...
This is a $20,264.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is for process development work related to vaccine candidates, including those for SARS-CoV-2. This award appears to be part of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle that IAVI holds with NIAID for preclinical services supporting...
This is a $26,065,720.00 cost-plus-fixed-fee delivery order awarded to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is for the manufacture of human flu challenge material, which supports IAVI's mission to develop safe and effective preventive vaccines for infectious diseases. The award is part of IAVI's existing indefinite...
This is a delivery order award to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, under a broader master contract with the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The $21,065 award is for the manufacturing of master cell banks to support pandemic preparedness and the development of a COVID-19 vaccine. This delivery order is not set aside and is part of IAVI's broader IDIQ contract...
This is a $1,327,640.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for "COORDINATION AND TECHNICAL SUPPORT" under NIAID's program for "PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES". IAVI, as the prime contractor, will provide a...
This is a $177,790.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for COORDINATION AND TECHNICAL SUPPORT services under NIAID's PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES major program. This contract is not designated as a set-aside. IAVI, as the prime contractor, will provide a range of research,...
This is a 5-year, $13,112,613 cost-type contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI) for "Staged Vaccine Development: Immunoprophylaxis by Gene Transfer." IAVI is a global non-profit organization that conducts research and development to advance the creation and delivery of vaccines and antibodies to prevent infectious diseases worldwide. This...
This $8,398,301.00 cost-reimbursement delivery order was awarded on December 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is part of NIAID's Preclinical And Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) program and will support IAVI's preclinical and translational vaccine development work for HIV and other infectious diseases through...
This federal contract award, valued at $16,731,358.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to the Access To Advanced Health Institute (AAHI), a non-profit biotech research institute. The contract is for the continued development of vaccine candidates for biodefense, antimicrobial resistance, emerging infectious diseases, and respiratory pathogens. No set-aside designation was used. AAHI has subcontracted with several institutions, including Emory...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $432,452.00 cost-plus-fixed-fee delivery order contract to the International AIDS Vaccine Initiative (IAVI), a non-profit organization, for a feasibility assessment of HIV envelope protein antigens. The contract does not have a set-aside designation. IAVI has conducted research, development, and advocacy to advance vaccines and antibodies for infectious...